About Respiro Health
Respiro Health is a Pune-based health-technology company developing AI-powered tools for respiratory disease pre-screening — designed from the ground up for India's scale, infrastructure constraints, and disease burden.
Our Mission
Respiratory diseases — tuberculosis, COPD, asthma, bronchitis — are among India's most significant public health challenges. Most patients present at an advanced stage of disease, not because early signs weren't there, but because the tools to act on them early don't reach where patients are.
Respiro's mission is to change that — by building a respiratory AI screening model designed for zero-barrier, low-bandwidth deployment on the smartphones patients already carry, reaching 500 million Indians without an app download or any new clinical infrastructure.
What We Build
A zero-infrastructure model that analyses cough recordings to pre-screen individuals for respiratory disease — being trained on confirmed-diagnosis data from real Indian OPDs under real acoustic conditions.
A multi-centre data collection platform capturing a 38-item structured clinical intake alongside cough recordings — building India's first confirmed-diagnosis acoustic respiratory dataset.
A prospective multi-centre observational study targeting 30,000+ confirmed-diagnosis recordings across geographies — in active collaboration with leading chest and pulmonary medicine departments across India.
A low-bandwidth delivery pipeline engineered to run over universal messaging channels — enabling point-of-first-contact triage without forcing patient app installations or specialised clinic hardware.
Where We Are — September 2026
Respiro Health is incorporated in Pune, Maharashtra. The company was built from the ground up by a solo technical founder — the entire data collection pipeline, AWS backend, messaging integration, and coordinator application operational within six months of incorporation.
Our research programme spans six epidemiological zones nationally. The Southern Zone has an MoU in final stages. Active institutional discussions are underway across the North-Central, Western, Eastern, and Capital Zones, with outreach active in the Western Himalayan and Northeast Zones. Legal counsel is retained. CTRI registration is in preparation.
Every previous acoustic respiratory AI was trained on controlled laboratory audio and validated on the same. Deployed in real-world clinical conditions — OPD noise, consumer microphones, real-world audio compression — accuracy collapsed. Respiro is training on real-world compressed audio from real OPDs, linked to molecularly confirmed diagnoses — the same conditions the model will be deployed in.